| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |